Glipizide
- Product NDC
- 70518-2573
- 11-digit product format
- 705182573
- Labeler code
- 70518
- Product ID
- 70518-2573_efe2521f-73b4-4d20-e053-2995a90a9cae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2020-02-18
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2573 | GLIPIZIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 5 | Legacy NDC | 20240302_2f8ae960-4627-4d78-ab3e-42bdc6877b01.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2573-0 | 70518257300 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2573-0) | 2020-02-18 | 0000-00-00 | No | No | Current |